Synthetic drug reverses serious liver damageTimes of IndiaWASHINGTON: Scientists have developed a synthetic drug that can reverse fatty liver disease, a serious metabolic condition involving an abnormal build-up of fat in the liver, which damages the o…
Cultural, social factors identified as barriers to minority participation in … – Medical Xpress
Cultural, social factors identified as barriers to minority participation in …Medical XpressDuring this stage of the donation process (called the CT stage), in which potential donors are contacted for confirmatory HLA typing blood tests and receive i…
"Hyperphosphatemia in Chronic Kidney Disease – Pipeline Review, H2 2012 … – SBWire (press release)
|
“Hyperphosphatemia in Chronic Kidney Disease – Pipeline Review, H2 2012 …
SBWire (press release) This report provides information on the therapeutic development for Hyperphosphatemia In Chronic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the … |
Neighborhood News: Live-tweeted kidney transplant
Big box buck, bicycle safety, and more Atlanta neighborhood news by Max Blau [ Subscribe to the comments on this story ]
BJB Friends holds blood donation camp – Daily Pioneer
|
BJB Friends holds blood donation camp
Daily Pioneer The BJB Friends (Ex-Students’ Association) organised a blood donation camp in the BJB Friends campus here on Wednesday which was inaugurated by the Principal of the BJB (Autonomous) College Suresh Chandra Patnaik. A total of 65 units of blood were … |
Surgeons conduct multi-organ transplant
A SWISS hospital says lessons learned from a recent complex, multi-organ transplant will benefit patients with tumours that attack multiple organs.
United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology …
NEW YORK, Dec. 20, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: United States In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry …
Gliknik Announces Interim Clinical Data From Use Of Its Immunomodulator Drug Candidate In Multiple Myeloma Patients
BALTIMORE, Dec. 20, 2012 /PRNewswire/ — Gliknik Inc., a privately held biopharmaceuticals company, today announced that researchers from University of Pennsylvania and University of Maryland presented …
New portable artificial heart allows 'normal' lifestyle while awaiting donor
SynCardia’s Total Artificial Heart was originally used as a permanent replacement heart, but is presently approved as a bridge to transplant for people dying from end-stage biventricular heart failure.
New portable artificial heart allows 'normal' lifestyle while awaiting donor – GMA News
|
New portable artificial heart allows ‘normal’ lifestyle while awaiting donor
GMA News It provides a high volume of blood-flow through both ventricles, which helps to speed the recovery of vital organs and make the patient a better candidate for transplant surgery. Once the total artificial heart is implanted, it is connected by two … |